We are excited to announce that Wim Van Hecke, PhD, has joined the RheumaFinder board! Wim is a pioneer in AI-driven medical imaging, best known as the founder and CEO of icometrix—a company that has set the absolute standard for…
Making the complex EU AI Act more accessible for pathology labs is crucial for safe and effective AI adoption in healthcare. That’s why, through a great collaboration - including our CMO Thomas Van Den Berghe, a practical checklist and framework…
At RheumaFinder, we proudly join the global community to highlight the significance of rheumatic and musculoskeletal diseases (RMDs). These conditions affect millions worldwide, posing daily challenges and requiring urgent attention in terms of education, awareness, and advocacy. The Importance of…
We are pleased to announce that RheumaFinder will be participating in this year's European Society for Musculoskeletal Radiology (ESSR) Annual Meeting in Toulouse. From June 19-21, our CEO, Nicolaas Fosselle, will be at our booth nr 22, engaging in insightful…
Today, May 20th, marks World AutoImmune Arthritis Day—a global initiative dedicated to raising awareness and shaping the conversation around autoimmune and autoinflammatory arthritis. At RheumaFinder, we are wholeheartedly aligned with AiArthritis’ mission to ensure that those affected have a leading…
Introduction On May 3rd, we commemorate World Axial Spondyloarthritis (AxSpA) Day, an important occasion to raise awareness about this chronic rheumatic disease. AxSpA can significantly impact the lives of those affected, causing severe pain and stiffness in the lower back,…
Het project CrossCare 2.0 stimuleert, ondersteunt en versnelt innovaties in de zorg. RheumaFinder maakt gebruik van dit programma om de implementatie van AI-gestuurde beeldanalyse voor vroege detectie van reumatische aandoeningen te optimaliseren binnen ziekenhuizen. Dankzij CrossCare kan RheumaFinder zijn technologie testen, bevragen en doorontwikkelen in samenwerking met zorginstellingen…
We are pleased to share insights from our co-founder, Prof. Lennart Jans, recently featured in EOS magazine. The article delves into the transformative role of artificial intelligence (AI) in healthcare, a field where RheumaFinder is making significant strides. Click here…
We are excited to announce our upcoming conference engagements for the spring season, where RheumaFinder will be actively participating and showcasing our innovative solutions for the early detection of rheumatic diseases. Biotrinity – April 1-2, London Join us at…
At RheumaFinder, we are constantly seeking innovative solutions to improve the detection and treatment of rheumatic diseases. Recently, we posed a thought-provoking question: What if we could detect rheumatic diseases up to 10 years before a diagnosis is made? This…